Cyr61/CCN1 affects the integrin-mediated migration of prostate cancer cells (PC-3) in vitro

International Journal of Clinical Pharmacology and Therapeutics

Volumn 51, Issue 1, 2013, Pages 47-50

  Schmitz, Patrick ^a   Gerber, Ursula ^a   Jun̈gel, Eva ^b   Schuẗze, Norbert ^c   Blaheta, Roman ^b   Bendas, Gerd ^a  

^a UNIVERSITY OF BONN   (Germany)

^b UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^c UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

CCN Cyr61; Collagen; ECM; Fibronectin; Integrins; Migration; Prostate cancer cells (PC 3)

Indexed keywords

ALPHA1 INTEGRIN; ALPHA4 INTEGRIN; ALPHA5 INTEGRIN; BETA3 INTEGRIN; CD51 ANTIGEN; COLLAGEN; CYSTEINE RICH PROTEIN 61; FIBRONECTIN RECEPTOR; INTEGRIN; VERY LATE ACTIVATION ANTIGEN 5;

ARTICLE; CANCER CELL; CELL CLONE; CELL MIGRATION; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; PROTEIN EXPRESSION; WESTERN BLOTTING;

BLOTTING, WESTERN; CELL LINE, TUMOR; CELL MOVEMENT; CYSTEINE-RICH PROTEIN 61; FLOW CYTOMETRY; HUMANS; INTEGRINS; MALE; PROSTATIC NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 84871912285     PISSN: 09461965     EISSN: None     Source Type: Journal    
DOI: 10.5414/CPP51047     Document Type: Article

References (3)

1. Lau LF. CCN1/CYR61: the very model of a modern matricellular protein. Cell Mol Life Sci. 2011; 68: 3149-3163. doi:10.1007/s00018-011-0778-3 PubMed
2. Liang C-C, Park AY, Guan J-L. In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro. Nat Protoc. 2007; 2: 329-333. doi:10.1038/nprot.2007.30 PubMed (Pubitemid 47040047)
3. Bendas G, Borsig L. Cancer cell adhesion and metastasis: selectins, integrins, and the inhibitory potential of heparins. Int J Cell Biol. 2012; 2012: 676731. PubMed